96 related articles for article (PubMed ID: 15961576)
1. Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV.
Lu KT; Dryer RL; Song C; Covey LR
J Leukoc Biol; 2005 Sep; 78(3):620-9. PubMed ID: 15961576
[TBL] [Abstract][Full Text] [Related]
2. c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.
Lu KT; Sinquett FL; Dryer RL; Song C; Covey LR
Blood; 2006 Dec; 108(12):3769-76. PubMed ID: 16896156
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
Kilger E; Kieser A; Baumann M; Hammerschmidt W
EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
[TBL] [Abstract][Full Text] [Related]
4. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
Bhushan A; Barnhart B; Shone S; Song C; Covey LR
J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
[TBL] [Abstract][Full Text] [Related]
5. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.
Graham JP; Arcipowski KM; Bishop GA
Immunol Rev; 2010 Sep; 237(1):226-48. PubMed ID: 20727039
[TBL] [Abstract][Full Text] [Related]
6. LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1.
Rastelli J; Hömig-Hölzel C; Seagal J; Müller W; Hermann AC; Rajewsky K; Zimber-Strobl U
Blood; 2008 Feb; 111(3):1448-55. PubMed ID: 18006702
[TBL] [Abstract][Full Text] [Related]
7. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.
Xie P; Hostager BS; Bishop GA
J Exp Med; 2004 Mar; 199(5):661-71. PubMed ID: 14981114
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.
Zimber-Strobl U; Kempkes B; Marschall G; Zeidler R; Van Kooten C; Banchereau J; Bornkamm GW; Hammerschmidt W
EMBO J; 1996 Dec; 15(24):7070-8. PubMed ID: 9003782
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
10. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.
Gires O; Zimber-Strobl U; Gonnella R; Ueffing M; Marschall G; Zeidler R; Pich D; Hammerschmidt W
EMBO J; 1997 Oct; 16(20):6131-40. PubMed ID: 9359753
[TBL] [Abstract][Full Text] [Related]
11. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
12. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
Floettmann JE; Ward K; Rickinson AB; Rowe M
Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
[TBL] [Abstract][Full Text] [Related]
13. Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L.
Bonnefoy JY; Gauchat JF; Life P; Graber P; Mazzei G; Aubry JP
Eur Respir J Suppl; 1996 Aug; 22():63s-66s. PubMed ID: 8871046
[TBL] [Abstract][Full Text] [Related]
14. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
[TBL] [Abstract][Full Text] [Related]
15. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
Peng M; Lundgren E
Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
17. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.
Uchida J; Yasui T; Takaoka-Shichijo Y; Muraoka M; Kulwichit W; Raab-Traub N; Kikutani H
Science; 1999 Oct; 286(5438):300-3. PubMed ID: 10514374
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
[TBL] [Abstract][Full Text] [Related]
19. B-cell expansion and lymphomagenesis induced by chronic CD40 signaling is strictly dependent on CD19.
Hojer C; Frankenberger S; Strobl LJ; Feicht S; Djermanovic K; Jagdhuber F; Hömig-Hölzel C; Ferch U; Ruland J; Rajewsky K; Zimber-Strobl U
Cancer Res; 2014 Aug; 74(16):4318-28. PubMed ID: 24938766
[TBL] [Abstract][Full Text] [Related]
20. Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.
Stunz LL; Busch LK; Munroe ME; Sigmund CD; Tygrett LT; Waldschmidt TJ; Bishop GA
Immunity; 2004 Aug; 21(2):255-66. PubMed ID: 15308105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
